Purchase Order 75S20123P00004
Award Date 9/11/23
Potential Completion Date 9/10/24
Potential Value $250K
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Denver, CO 80204, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by a civilian federal agency to the Denver Health and Hospital Authority, a U.S. local government entity. The $249,999.99 contract is for the purpose of launching a survey focused on tracking changing motivations and contextual factors associated with the use of psychedelics/hallucinogens. The award has no set-aside designation. Denver Health and Hospital Authority is a comprehensive healthcare system with extensive experience in data collection,...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Denver Health and Hospital Authority, doing business as Denver Health, for $695,889.00. The contract is for data resources to support post-marketing surveillance of nonmedical use of pharmaceuticals and use of illicit drug substances. Denver Health is a comprehensive healthcare system in Denver, Colorado that serves as a provider of medical services, public health programs, and research initiatives for...
- The Department of Health and Human Services Food and Drug Administration awarded a definitive firm fixed price contract valued at approximately $1.1 million to Denver Health and Hospitals Authority for an evaluation of stimulant abuse in the United States. Denver Health will deliver a mosaic epidemiology study to assess stimulant abuse patterns across the country under the two-year contract set to run from September 2020 through September 2022. As the prime contractor, Denver Health will...
- Denver Health and Hospitals Authority has been awarded a firm fixed price delivery order against the FDA's contract vehicle for $205,010. The order is for a survey of non-medical use of prescription drugs to collect data on selected drugs of interest. Performance will take place in Denver, Colorado and be completed by September 1, 2024. No set-aside designation was used for this order. As the prime contractor, Denver Health will provide data collection and analytics services to the Food and Drug...
- The Food and Drug Administration (FDA) awarded a delivery order valued at $816,801.67 to Denver Health and Hospital Authority (doing business as Denver Health) on September 20, 2019, for work related to improving the quality and representativeness of Treatment Center Program data used in post-marketing surveillance of prescription and over-the-counter drug abuse. The contract, which operates under firm fixed-price terms with an ultimate completion date of March 5, 2026, represents work to be...
- This is a task order awarded to the Denver Health and Hospital Authority, doing business as Denver Health, by the Food and Drug Administration (FDA). The task order is titled "Data Resource for Post-Marketing Prescription and Over-the-Counter Drug Abuse Surveillance Data from Individuals Entering or Being Assessed for Substance Abuse Treatment Summary Reports." The contract is a firm fixed price delivery order under the FDA Prescription Drug Abuse Summary Reports contract vehicle, with...
- The Food and Drug Administration (FDA) awarded Denver Health and Hospital Authority a $630,211 delivery order on August 31, 2022, to conduct survey research on the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among a general population recruited through an online panel survey. This delivery order operates under the FDA's $10 million multiple-award Indefinite Delivery Contract (IDC) for data resources supporting post-marketing surveillance of...
- This is a $38,403.00 Firm Fixed Price Delivery Order awarded by the Food and Drug Administration (FDA) to Denver Health and Hospital Authority, doing business as Denver Health, a comprehensive healthcare system in Denver, Colorado. The order is for a task titled "Drug Specific Report- Route of Abuse Patterns for Opana ER and Selected Comparator Opioids among Individuals Entering Treatment for Opioid Addictions." This order is placed under the FDA's Prescription Drug Abuse Summary...
- This is a federal contract awarded by the Department of Health and Human Services' Food and Drug Administration to the Denver Health and Hospital Authority. The $427,972.40 contract is for a "DATA ENHANCEMENT PROJECT" to support the FDA's post-marketing prescription and over-the-counter drug abuse surveillance data. The work is being performed under the FDA Prescription Drug Abuse Summary Reports contract vehicle. The contract does not have a set-aside designation. As a U.S. local...
- This is a federal contract award from the Substance Abuse and Mental Health Services Administration (SAMHSA), a division of the Department of Health and Human Services, to the prime contractor Research Triangle Institute (RTI International). The contract is for the "2018-2022 National Survey on Drug Use and Health (NSDUH)", which is a major research program focused on substance abuse and mental health. The contract has a ceiling value of $309,011,214.00 and does not have a set-aside...